clomiPRAMINE Hydrochloride Capsules USP recall
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC…
Why was clomiPRAMINE Hydrochloride Capsules USP recalled?
Failed Tablet/Capsule Specification
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# 20P0141, exp. date 02/2022
- Product
- clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC…
- Recalling firm
- Jubilant Cadista Pharmaceuticals, Inc.
- Quantity
- 4,416 bottles
- Distribution
- Product was distributed nationwide.
- Recall date
- December 2, 2020
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)